Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
METRONIC Global Bhd is expecting US$1 bil in revenue – which is more than five times its current market capitalisation of RM169 mil – for its worldwide monopoly of the COVID-19 Immune System Test Kit supply chain.
The company said it has received pre-orders for a total of 50 million test kits from companies within the Southeast Asia Region, prompting its order book to swell by US$350 mil.